Quantitative Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,751	Closed	-$936K	–	393
2025 Q4	$936K	Buy	+15,751	New	+$858K	0.09%	216
2024 Q1	–	Sell	-11,565	Closed	-$1.11M	–	253
2023 Q4	$1.11M	Buy	+11,565	New	+$1.02M	0.06%	246
2023 Q1	–	Sell	-23,163	Closed	-$2.4M	–	232
2022 Q4	$2.4M	Buy	23,163 +18,854	+438%	+$1.77M	0.46%	48
2022 Q3	$365K	Buy	+4,309	New	+$384K	0.06%	217
2022 Q1	–	Sell	-5,846	Closed	-$516K	–	209
2021 Q4	$516K	Buy	+5,846	New	+$482K	0.07%	175
2021 Q3	–	Sell	-22,070	Closed	-$1.84M	–	399
2021 Q2	$1.84M	Buy	+22,070	New	+$1.75M	0.17%	133
2021 Q1	–	Sell	-25,775	Closed	-$2.26M	–	507
2020 Q4	$2.26M	Buy	+25,775	New	+$2.04M	0.18%	133
2017 Q4	–	Sell	-15,800	Closed	-$1.47M	–	756
2017 Q3	$1.47M	Buy	15,800 +2,000	+14%	+$177K	0.02%	538
2017 Q2	$1.25M	Buy	+13,800	New	+$1.26M	0.02%	559
2016 Q2	–	Sell	-28,900	Closed	-$2.38M	–	749
2016 Q1	$2.38M	Buy	+28,900	New	+$2.35M	0.12%	220
2015 Q3	–	Sell	-4,900	Closed	-$670K	–	686
2015 Q2	$670K	Buy	+4,900	New	+$607K	0.1%	186
2015 Q1	–	Sell	-4,900	Closed	-$442K	–	626
2014 Q4	$442K	Sell	4,900 -1,800	-27%	-$150K	0.07%	288
2014 Q3	$483K	Buy	+6,700	New	+$440K	0.09%	181
2014 Q2	–	Sell	-50,600	Closed	-$3.45M	–	470
2014 Q1	$3.45M	Buy	+50,600	New	+$3.73M	0.16%	87
2013 Q4	–	Sell	-39,300	Closed	-$2.84M	–	573
2013 Q3	$2.84M	Buy	+39,300	New	+$2.61M	0.25%	78